Article Text


SAT0158 Associates with and extent of reduced bone mineral density (bmd) in female rheumatoid arthritis (ra) patients: the oslo, truro, amsterdam (ostra) collaborative study
  1. G Haugeberg1,
  2. M Lodder2,
  3. W Lems2,
  4. T Uhlig1,
  5. B Dijkmans2,
  6. T Kvien1,
  7. A Woolf3
  1. 1Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  2. 2Department of Rheumatology, Vrije Universiteit, Amsterdam, Netherlands
  3. 3Department of Rheumatology, Royal Cornwall Hospital, Truro, UK


Objectives To examine associates with and occurrence of reduced BMD in female RA patients from three European countries.

Methods 150 (50 from each country) consecutive female RA patients (ACR 1987 criteria, disease duration ≥5 yrs, age 50–70 yrs), visiting the out-patient rheumatology clinics were included. Study variables included clinical data, laboratory tests, hand X-ray (Larsen score) and BMD measurement. BMD (g/cm2) was measured by dual energy X-ray absorptiometry (DXA) and adjusted for age, weight and height. A pooled European/US reference population, showing no substantial differences with published Norwegian, English, and Dutch reference populations, was used to calculate T-scores. Groups were compared by one way ANOVA and cross tabulation (Pearson Chi square test). To investigate associates for BMD reduction bi- and multi-variety statistical analyses were performed.

Results No significant differences between the countries were found for age, disease duration and rheumatoid factor, whereas weight and most disease related variables, including the use of prednisolone and treatment for osteoporosis, differed between the 3 groups. Percentage of patients having osteoporosis (T-score <-2.5 SD) at femoral neck was 21.3% in Oslo, 8.3% in Truro, and 18.4% in Amsterdam (P = 0.19) and at the spine 32.0%, 18.4% and 12.0% (P = 0.04), respectively. Mean (SD) BMD values are shown in the Table 1. Using multivariate linear regression age, weight, total hand X-ray Larsen score, previous history of clinical fracture and ever use of DMARDs were independent associates for femoral neck BMD. For spine L2–4 weight, mean CRP last 12 months, ever use of DMARDs and current use of prednisolone were independent associates.

Abstract SAT0158 Table 1

Conclusion Differences in femoral neck and spine BMD might reflect differences in life styles factors, disease activity and disease management between the countries.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.